Intravitreal Nesvacumab plus Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial

被引：0
|
作者：
Boyer, David S. [1 ]
机构：
[1] Retina Vitreous Assoc Med Grp, Ophthalmol, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3620
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Week 48 Efficacy Outcomes by Baseline Demographics in the Phase 2/3 PHOTON Trial
    Ghorayeb, Ghassan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [22] EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANT TREATMENT IN DIABETIC MACULAR EDEMA REFRACTORY TO INTRAVITREAL AFLIBERCEPT TREATMENT
    Celik, E.
    Sever, O.
    Cakir, B.
    Dogan, E.
    Ozmen, S.
    Atum, M.
    Aksoy, N.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP29 - NP29
  • [23] A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema
    Scott, Ingrid U.
    Edwards, Allison R.
    Beck, Roy W.
    Bressler, Neil M.
    Chan, Clement K.
    Elman, Michael J.
    Friedman, Scott M.
    Greven, Craig Michael
    Maturi, Raj K.
    Pieramici, Dante J.
    Shami, Michel
    Singerman, Lawrence J.
    Stockdale, Cynthia R.
    OPHTHALMOLOGY, 2007, 114 (10) : 1860 - 1867
  • [24] Intravitreal Aflibercept reduces the retinal vessel diameter in patients with diabetic macular edema
    Consigli, Andrea
    Papanastasiou, Athanasios
    Roy, Sayon
    Thumann, Gabriele
    Chronopoulos, Argyrios
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [25] INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: A Pilot Study
    de Andrade, Gabriel Costa
    de Oliveira Dias, Joao Rafael
    Maia, Andre
    Farah, Michel Eid
    Meyer, Carsten H.
    Rodrigues, Eduardo Buchele
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (09): : 1640 - 1645
  • [26] Efficacy of the combination of intravitreal aflibercept and triamcinolone injections in treatment of diabetic macular edema
    Liu, Yiwen
    Liu, Lan
    Chen, Peng
    Zhao, Yue
    Liang, Pengcheng
    Wang, Xi
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (12) : 2497 - 2504
  • [27] Efficacy and tolerance of Aflibercept intravitreal injection in vitrectomized eyes with diabetic macular edema
    Erginay, Ali
    Baillif, Stephanie
    Fourmiaux, Eric
    Lerouic, Jean Francois
    Uzzan, Joel
    Milazzo, Solange
    Kodjikian, Laurent
    Thi Ha Chau Tran
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [28] Multiple Effects of Intravitreal Aflibercept on Microvascular Regression in Eyes with Diabetic Macular Edema
    Sugimoto, Masahiko
    Ichio, Atushi
    Mochida, Daiki
    Tenma, Yumiho
    Miyata, Ryohei
    Matsubara, Hisashi
    Kondo, Mineo
    OPHTHALMOLOGY RETINA, 2019, 3 (12): : 1067 - 1075
  • [29] Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
    Herbaut, Antoine
    Fajnkuchen, Franck
    Qu-Knafo, Lise
    Nghiem-Buffet, Sylvia
    Bodaghi, Bahram
    Giocanti-Auregan, Audrey
    JOURNAL OF OPHTHALMOLOGY, 2017, 2017
  • [30] Effect of intravitreal aflibercept in prior treated patients with persistent diabetic macular edema
    Freiberg, Florentina Joyce
    Becker, Matthias
    Johansen, Nicole Tracy Graf
    Michels, Stephan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345